ArticleHealthcare (Basel, Switzerland)2020
Lyme Disease: Diversity of
Article in Healthcare (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- New host record of Amblyomma pakhtunensis on the Indian Pangolin (Manis crassicaudata) with detection of a distinct Borrelia lineage.Scientific reports · 2026Article
- Prevalence ofPathogens (Basel, Switzerland) · 2025Article
- Molecular detection of Rickettsia aeschlimannii, Borrelia theileri, and Francisella-like endosymbionts in Camelus dromedarius and dogs in Luxor, Egypt.Scientific reports · 2025Article
- Genetic Diversity ofLife (Basel, Switzerland) · 2023Article
- Molecular evidence ofFrontiers in veterinary science · 2023Article
- Triangulating the New Frontier of Health Geo-Data: Assessing Tick-Borne Disease Risk as an Occupational Hazard among Vulnerable Populations.International journal of environmental research and public health · 2022Article
- Possible Association between Selected Tick-Borne Pathogen Prevalence andPathogens (Basel, Switzerland) · 2022Article
- Molecular Detection of Tick-Borne Pathogens in American Bison (Pathogens (Basel, Switzerland) · 2021Article
- Dermatological and Genital Manifestations of Lyme Disease Including Morgellons Disease.Clinical, cosmetic and investigational dermatology · 2021Article
- Detection ofPathogens (Basel, Switzerland) · 2020Article
- Presentation of Acrodermatitis Chronica Atrophicans Rashes on Lyme Disease Patients in Canada.Healthcare (Basel, Switzerland) · 2020Article
- Classification and Staging of Morgellons Disease: Lessons from Syphilis.Clinical, cosmetic and investigational dermatology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundWith more than 300,000 new cases reported each year in the United States of America (USA), Lyme disease is a major public health concern.
methodsSerum samples were tested for seroreactivity to specific species of Bbsl and RFB using an immunoblot method based on recombinant
resultsThe patient cohort consisted of 90 patients residing in California or Mexico who met the clinical case definition of chronic Lyme disease. Immunoblot testing revealed that 42 patients were seropositive for Bbsl (Group 1), while 56 patients were seropositive for RFB (Group 2). Eight patients were seropositive for both Bbsl and RFB species. Group 1 included patients who were seropositive for Bbss (14),
conclusionsLyme disease is associated with a diverse group of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.